Innovative new strategy to treat Parkinson's disease

Stabilizing the cell's power-generating center protects against Parkinson's disease (PD) in a rat model, according to a report published online this week in the Journal of Experimental Medicine.

Mitochondria -- the energy production center of cells -- are damaged in PD, leading to loss of dopaminergic neurons and degeneration of brain function. Taking advantage of the fact that viruses often stabilize mitochondria in order to ensure survival of the cells they infect, a team led by John Sinclair and Roger Barker at the University of Cambridge injected a viral protein called beta2.7, known to protect mitochondria, into rats with a PD-like disease.

Rats injected with this beta2.7 before or after the formation of PD-like performed better on tests of behavior and motor function. Their brains also contained more dopaminergic neurons. Further work is needed to determine if the same approach will also benefit human .

More information: Kuan, W.-L., et al. 2011. J. Exp. Med. doi:10.1084/jem.20111126

add to favorites email to friend print save as pdf

Related Stories

Lessons from yeast: A possible cure for Parkinson's disease?

Aug 14, 2008

Parkinson disease (PD) is a debilitating and lethal neurodegenerative disease, for which there is currently no cure. It is caused by the progressive loss of nerve cells that produce the chemical dopamine and is characterized ...

Recommended for you

A novel therapy for sepsis?

10 hours ago

A University of Tokyo research group has discovered that pentatraxin 3 (PTX3), a protein that helps the innate immune system target invaders such as bacteria and viruses, can reduce mortality of mice suffering ...

Cellular protein may be key to longevity

Sep 15, 2014

Researchers have found that levels of a regulatory protein called ATF4, and the corresponding levels of the molecules whose expression it controls, are elevated in the livers of mice exposed to multiple interventions ...

Gut bacteria tire out T cells

Sep 15, 2014

Leaky intestines may cripple bacteria-fighting immune cells in patients with a rare hereditary disease, according to a study by researchers in Lausanne, Switzerland. The study, published in The Journal of Experimental Me ...

User comments